Thorac Cardiovasc Surg 1986; 34(3): 149-152
DOI: 10.1055/s-2007-1020398
© Georg Thieme Verlag Stuttgart · New York

Valve Replacement in Acute Native Valve Endocarditis

R. Soyer, M. Redonnet, J. P. Bessou, P. Mutel, C. Hubscher, B. Letac
  • Department of Thoracic and Cardiovascular Surgery, Hospital Charles Nicolle, University of Rouen, France
Weitere Informationen

Publikationsverlauf

1985

Publikationsdatum:
29. Mai 2008 (online)

Summary

From 1974 to 1984, 46 patients underwent emergency surgery for acute native valve endocarditis. Urgent valve replacement was necessary because of rapid hemodynamic deterioration in 34 (73 %), uncontrolled sepsis plus heart failure in 9 (19%), and life-threatening emboli in 3 (7%) patients. At the time of surgery 23 patients (50%) were in NYHA functional class IV, 20 in class III, and 3 in class II.

Streptococcus was the most common organism encountered, followed by staphylococcus. Thirty-four cases presented severe aortic regurgitation, 3 mitral incompetence, 8 mitral plus aortic insufficiency, and one aortic plus tricuspid insufficiency. Operative mortality rate was 17% (8/46). Most deaths were due to preoperative multiple system deterioration, especially in cases with lesions of both the aortic and mitral valves, and were unrelated to the duration of preoperative antibiotic therapy. The postoperative observation period of long-term survival is from 6 to 102 months (= 44 months). There were 7 late deaths. The actuarial survival, including operative mortality, is 67%. Twenty-two patients are now in NYHA class II, 6 in class III. The duration of postoperative antibiotic treatment (6 weeks in our series) seems to be important for the prevention of reinfection, early surgery is of great benefit; our 31 survivors showed an excellent clinical improvement.